BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25521438)

  • 1. Colorectal Cancer Screening and State Health Insurance Mandates.
    Hamman MK; Kapinos KA
    Health Econ; 2016 Feb; 25(2):178-91. PubMed ID: 25521438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between state mandates of colorectal cancer screening coverage and colorectal cancer screening utilization among US adults aged 50 to 64 years with health insurance.
    Cokkinides V; Bandi P; Shah M; Virgo K; Ward E
    BMC Health Serv Res; 2011 Jan; 11():19. PubMed ID: 21272321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health Insurance Coverage Mandates: Colorectal Cancer Screening in the Post-ACA Era.
    Preston MA; Ross L; Chukmaitov A; Smith SA; Odlum ML; Dahman B; Sheppard VB
    Cancer Prev Res (Phila); 2021 Jan; 14(1):123-130. PubMed ID: 32917646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insurance coverage mandates: Impact of physician utilization in moderating colorectal cancer screening rates.
    Preston MA; Mays GP; Bursac Z; Thomas BR; Laryea J; Tilford JM; Odlum M; Smith SA; Henry-Tillman RS
    Am J Surg; 2018 Jun; 215(6):1004-1010. PubMed ID: 29555083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mandated coverage of preventive care and reduction in disparities: evidence from colorectal cancer screening.
    Hamman MK; Kapinos KA
    Am J Public Health; 2015 Jul; 105 Suppl 3(Suppl 3):S508-16. PubMed ID: 25905835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer screening in the United States: Trends from 2008 to 2015 and variation by health insurance coverage.
    de Moor JS; Cohen RA; Shapiro JA; Nadel MR; Sabatino SA; Robin Yabroff K; Fedewa S; Lee R; Paul Doria-Rose V; Altice C; Klabunde CN
    Prev Med; 2018 Jul; 112():199-206. PubMed ID: 29729288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Making the case: the impetus for federally mandating insurance companies to cover colorectal cancer screening.
    Toomey A; Menon U
    Soc Work Public Health; 2010 Jan; 25(1):92-101. PubMed ID: 20391254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of State Cervical Cancer Insurance Mandates on Pap Test Rates.
    Bitler MP; Carpenter CS
    Health Serv Res; 2017 Feb; 52(1):156-175. PubMed ID: 26989837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health Insurance Status and Clinical Cancer Screenings Among U.S. Adults.
    Zhao G; Okoro CA; Li J; Town M
    Am J Prev Med; 2018 Jan; 54(1):e11-e19. PubMed ID: 29102459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mandated coverage for cancer-screening services: whose guidelines do states follow?
    Rathore SS; McGreevey JD; Schulman KA; Atkins D
    Am J Prev Med; 2000 Aug; 19(2):71-8. PubMed ID: 10913895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health insurance-related disparities in colorectal cancer screening in Virginia.
    de Bosset V; Atashili J; Miller W; Pignone M
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):834-7. PubMed ID: 18398024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Association Between Primary Source of Healthcare Coverage and Colorectal Cancer Screening Among US Veterans.
    May FP; Yano EM; Provenzale D; Neil Steers W; Washington DL
    Dig Dis Sci; 2017 Aug; 62(8):1923-1932. PubMed ID: 28528373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How many individuals will need to be screened to increase colorectal cancer screening prevalence to 80% by 2018?
    Fedewa SA; Ma J; Sauer AG; Siegel RL; Smith RA; Wender RC; Doroshenk MK; Brawley OW; Ward EM; Jemal A
    Cancer; 2015 Dec; 121(23):4258-65. PubMed ID: 26308967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in screening for colorectal cancer in older Americans: results from a national survey.
    Chen X; White MC; Peipins LA; Seeff LC
    J Am Geriatr Soc; 2008 Aug; 56(8):1511-6. PubMed ID: 18662217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Completion of colorectal cancer screening in women attending screening mammography.
    Molina L; Carlos RC; Mark Fendrick A; Abrahamse PH; Dong Q; Bernstein SJ
    Acad Radiol; 2004 Nov; 11(11):1237-41. PubMed ID: 15561570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy?
    Schneider EC; Rosenthal M; Gatsonis CG; Zheng J; Epstein AM
    Med Care; 2008 Sep; 46(9 Suppl 1):S84-90. PubMed ID: 18725838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Influencing Adherence to Recommended Colorectal Cancer Surveillance: Experiences and Behaviors of Colorectal Cancer Survivors.
    Ford ME; Sterba KR; Armeson K; Malek AM; Knight KD; Zapka J
    J Cancer Educ; 2019 Oct; 34(5):938-949. PubMed ID: 30073494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vital signs: colorectal cancer screening among adults aged 50-75 years - United States, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jul; 59(26):808-12. PubMed ID: 20613704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Finance issue brief: mandated benefits: colorectal cancer screening coverage requirements: year end report-2003.
    Plaza CI; Rane S
    Issue Brief Health Policy Track Serv; 2003 Dec; ():1-5. PubMed ID: 14870753
    [No Abstract]   [Full Text] [Related]  

  • 20. Colorectal cancer screening behavior and health insurance status (United States).
    Matthews BA; Anderson RC; Nattinger AB
    Cancer Causes Control; 2005 Aug; 16(6):735-42. PubMed ID: 16049812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.